3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
1
Carcinoma, Basal Cell
1
Interventions
3-ingenyl angelate
42
Aminolevulinic Acid
34
Imiquimod
29
Fluorouracil
23
Photochemotherapy
22
methyl 5-aminolevulinate
14
Gels
12
Diclofenac
12
Cryotherapy
12
tirbanibulin
7
Solutions
7
BF-200 ALA
6
calcipotriene
5
Petrolatum
5
Ointments
5
LEO 43204
5
Radiotherapy
4
Prilocaine
4
Lidocaine
4
Therapeutics
3
Niacinamide
3
Cryosurgery
3
Biopsy
3
1-phenyl-3,3-dimethyltriazene
3
Tomography, Optical Coherence
2
SR-T100
2
Phototherapy
2
Imipramine
2
Deoxyribonuclease (Pyrimidine Dimer)
2
Celecoxib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Keratosis, Actinic
×
green tea extract polyphenone E
×
Dermatologic
×
Clear all
NCT07137819
2025-08-22
EXACT-1
Aresus Pharma GmbH
Phase 3
Recruiting
280 enrolled